logo
Plus   Neg
Share
Email

Sotheby's To Return To Private Ownership; Shareholders To Receive $57/share

Sotheby's (BID) has agreed to be acquired by BidFair USA, which is owned by entrepreneur Patrick Drahi, in a deal with an enterprise value of $3.7 billion. Sotheby's shareholders will receive $57.00 per share of the company's common stock. The transaction is anticipated to close in the fourth quarter of 2019.

Patrick Drahi is a global entrepreneur with telecommunications, media and digital properties across the globe. He is the Founder, President of the Board, and controlling shareholder of Altice Europe.

Domenico De Sole, Chairman of Sotheby's Board, said, "Following a comprehensive review, the Board enthusiastically supports Drahi's offer, which delivers a significant premium to market for our shareholders. After more than 30 years as a public company, the time is right for Sotheby's to return to private ownership to continue on a path of growth and success."

Shares of Sotheby's were up more than 58% in pre-market trade on Monday.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Home Depot Inc. (HD) on Tuesday reported 5.8 percent increase in fourth-quarter profit, while Macy's Inc. (M) fourth-quarter profit fell 54.1 percent. However, the results of the companies beat analysts' estimates. The retailers have reaffirmed their annual outlook. Healthcare insurer Aetna, a subsidiary of CVS Health Corp., announced the launch of Aetna Whole Health in Atlanta, providing fully insured and self-insured health care network options for employers. Aetna said through the program, it will offer the health care network options to its Health Maintenance Organization and Exclusive Product Organization product portfolios. Med Man Distribution expanded its recall for dietary supplements including all lots of "Bow and Arrow libido enhancer for men" for the potential undeclared presence of sildenafil, the U.S. Food and Drug Administration said in a statement. Sildenafil is an FDA-approved prescription drug for erectile dysfunction. The company had earlier in November 2019 recalled all lots of Up2 dietary supplement.
Follow RTT
>